Back

Combination of nicorandil and beta-adrenergic receptor blockers in patients with coronary heart disease: a real-world observational study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Drug-related risk management in chronic coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Ning Zhou

Tongji Medical College of Huazhong University of Science and Technology, Wuhan (China)

6 More presentations in this session

Presentation thumbnail
Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study
Doctor J. Shanmuganathan (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Non-clinical evaluation of YN001-a promising drug for atherosclerotic therapy by targeted delivery system
Doctor Q. Ma (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Cardioprotective potential of exosomes derived from blood outgrowth endothelial cells in ischemic cardiomyopathy
Doctor M. Wu (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
PSRC1 rs599839 G allele may promote protection from coronary artery disease in a Madeira Island population
Mr F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Effects on re-endothelialisation with Bydureon treatment add on to insulin versus insulin alone, both in combination with metformin in type 2 diabetic subjects: Rebuild study
Doctor I. Santos-Pardo (Badalona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Drug-related risk management in chronic coronary syndromes

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
thumbnail
Congress Presentation
The long-term usage of statin prevents adverse events in patients with atrial fibrillation
thumbnail
Congress Presentation
Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources